The fast-moving variant poses new puzzles in viral transmission, severity and evolution.
That’s good news, because although T cells are slower than antibodies to respond to a recurring threat, they’re effective once they get going. This helps to stop breakthrough infections from becoming severe.
The latter is what’s happened with each variant of concern so far. “It suggests that there’s a huge amount of plasticity in the virus,” says Lucy Thorne, a virologist at University College London. “It’s got different evolutionary options.” As the study authors note, changes in cell-culture dishes don’t necessarily mean that the virus would be any better at infecting animals or people; it’s possible the mutations might make it inept in other ways. Thus, this type of workResearchers can also put pressure on the virus in the lab, allowing it to evolve in the presence of antibodies or antiviral drugs.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Omicron’s lasting mysteries: four questions scientists are racing to answerThe fast-moving variant poses new puzzles in viral transmission, severity and evolution.
続きを読む »
Fourth dose of COVID vaccine offers only slight boost against Omicron infectionIsraeli trial shows a fourth vaccination raises antibody levels but provides little extra protection against SARS-CoV-2 infection.
続きを読む »
Fourth dose of COVID vaccine offers only slight boost against Omicron infectionIsraeli trial shows a fourth vaccination raises antibody levels but provides little extra protection against SARS-CoV-2 infection.
続きを読む »
Fourth dose of COVID vaccine offers only slight boost against Omicron infectionIsraeli trial shows a fourth vaccination raises antibody levels but provides little extra protection against SARS-CoV-2 infection.
続きを読む »
As 'stealth omicron' advances, scientists are learning more - New York Amsterdam NewsThe coronavirus mutant widely known as “stealth omicron” is now causing more than a third of new omicron cases around the world, but scientists still don’t know how it could affect the future of the pandemic.
続きを読む »
Moderna co-founder, mRNA developer says he's not completely surprised by vaccine hesitancyRobert Langer, one of the scheduled Imagine Solutions Conference speakers on March 7 in Naples, said the science behind the COVID-19 vaccine is revolutionary
続きを読む »